An Impaired Driver Found to be Under the Influence of Methoxetamine.
Timothy C Fassette, Afton Martinez
Journal of Analytical Toxicology October 1, 2016 DOI: 10.1093/jat/bkw054 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A 33-year-old female driver in Henderson, Nevada |
| Key findings | Methoxetamine was detected and confirmed in a blood sample from a DUI case, with a concentration of 160 ng/mL (NMS Labs) and 151 ng/mL (Henderson Police Department laboratory), marking the first such confirmed case in Nevada. |
Abstract
The popularity of designer drugs has increased over the past few years as users seek new, cheap and sometimes "legal" ways to get high. This case report focuses on a case that happened in the City of Henderson, Nevada, which involved the designer drug methoxetamine. Methoxetamine is a psychoactive compound that is structurally related to ketamine and reported to have similar effects. These effects include analgesia, cardiovascular and respiratory stimulation, and enhanced skeletal muscle tone. Presented here is a case of a 33-year-old female who was pulled over after almost colliding with a marked police motorcycle, causing the police officer to avoid the collision by running onto a pedestrian sidewalk. Upon stopping the vehicle and questioning the passengers, the officer learned that the driver of the vehicle had ingested methoxetamine earlier in the day. After the driver was taken into custody, a blood sample was drawn and sent to the laboratory for analysis. Initial screening of the blood sample showed presumptive positive results for the amphetamine enzyme-linked immunosorbent assay. The next day, a full scan screen of the blood sample was performed using the gas chromatography-mass spectrometry (GC/MS) and methoxetamine and dextromethorphan were detected. Since the laboratory did not have the ability to confirm methoxetamine, the sample was sent to NMS Labs for analysis. The results from NMS Labs showed a methoxetamine concentration of 160 ng/mL. To date, this is the first DUI case in the state of Nevada where methoxetamine was detected and confirmed. A short time after the NMS results were received, a full SWGTOX validation was performed on a new GC/MS method to confirm methoxetamine along with five synthetic cathinone analytes. After the GC/MS analysis validation was complete, the sample was subsequently reanalyzed for methoxetamine in the toxicology laboratory at the Henderson Police Department Forensic Science Laboratory and the result that attained was 151 ng/mL, which was in line with the result from NMS Labs.
Citations in the library
Cited by 7
- New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT2 receptors in pharmacological and behavioral effects in the rat. Experimental Neurology November 1, 2021
- Fluorodeschloroketamine found as a street drug in drug seizures and drug driving cases in Hong Kong. Forensic Science International August 1, 2024
- Arylcyclohexylamine Derivatives: Pharmacokinetic, Pharmacodynamic, Clinical and Forensic Aspects International Journal of Molecular Sciences December 1, 2022
- Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies. Neural Regeneration Research May 1, 2020
- Methoxetamine: A foe or friend? Neurochemistry International 2019
and 2 more in the library
Cites 3
- An accidental fatal intoxication with methoxetamine. Journal of Analytical Toxicology 2013
- Ketamine-like effects after recreational use of methoxetamine. Annals of emergency medicine July 1, 2012
- Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. European Journal of Clinical Pharmacology May 1, 2012